InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,715.60
(
0.23%
)
US TECH 100
19,318.00
(
0.11%
)
Dow Jones
42,103.19
(
0.09%
)
Brent Oil
73.38
(
-0.69%
)
Bitcoin
63,367.59
(
-0.41%
)

Replies to post #452436 on Anavex Life Sciences Corp (AVXL)

Replies to #452436 on Anavex Life Sciences Corp (AVXL)
icon url

Investor2014

02/22/24 8:50 AM

#452437 RE: WolfofMia #452436

Then search you failing memory.
icon url

Investor2014

02/22/24 10:19 AM

#452450 RE: WolfofMia #452436

I have posted many times, too many some believe, that further likely precision medicine P3 trials will be required. I stand by this likelihood and look forward to see which and how biomarkers correlate to benefit and dose versus placebo. This despite the '85% chance' of EMA approval of AD with A2-73 from the P2b/3 trial data.